Abstract:Bone regenerative medicine is a clinical approach combining live osteoblast progenitors, such as mesenchymal stromal cells (MSCs), with a biocompatible scaffold that can integrate into host bone tissue and restore its structural integrity. Over the last few years, many tissue engineering strategies have been developed and thoroughly investigated; however, limited approaches have been translated to clinical application. Consequently, the development and clinical validation of regenerative approaches remain a centerpiece of investigational efforts towards the clinical translation of advanced bioengineered scaffolds. The aim of this review was to identify the latest clinical trials related to the use of scaffolds with or without MSCs to regenerate bone defects. A revision of the literature was performed in PubMed, Embase, and Clinicaltrials.gov from 2018 up to 2023. Nine clinical trials were analyzed according to the inclusion criteria: six presented in the literature and three reported in Clinicaltrials.gov. Data were extracted covering background trial information. Six of the clinical trials added cells to scaffolds, while three used scaffolds alone. The majority of scaffolds were composed of calcium phosphate ceramic alone, such as β-tricalcium phosphate (TCP) (two clinical trials), biphasic calcium phosphate bioceramic granules (three clinical trials), and anorganic bovine bone (two clinical trials), while bone marrow was the primary source of the MSCs (five clinical trials). The MSC expansion was performed in GMP facilities, using human platelet lysate (PL) as a supplement without osteogenic factors. Only one trial reported minor adverse events. Overall, these findings highlight the importance and efficacy of cell–scaffold constructs in regenerative medicine under different conditions. Despite the encouraging clinical results obtained, further studies are needed to assess their clinical efficacy in treating bone diseases to optimize their application.

Use of allograft bone matrix in clinical orthopedics

A Cancellous Bone Matrix System with Specific Mineralisation Degrees for Mesenchymal Stem Cell Differentiation and Bone Regeneration

Is extracellular matrix (ECM) a promising scaffold biomaterial for bone repair?

The Bone Extracellular Matrix in Bone Formation and Regeneration

Demineralized Bone Matrix Carriers and their Clinical Applications: An Overview

Application of decellularized bone matrix as a bioscaffold in bone tissue engineering

Applications of decellularized extracellular matrix in bone and cartilage tissue engineering

Rapid Formation of 3D: Decellularized Extracellular Matrix Spheroids for Enhancing Bone Formation

Decellularized Extracellular Matrices in Bone Tissue Engineering: From Cells to Tissues. Mini-Review

Boosting osteogenic potential and bone regeneration by co-cultured cell derived extracellular matrix incorporated porous electrospun scaffold

Advancing application of mesenchymal stem cell-based bone tissue regeneration

Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering

Demineralized bone matrix in bone repair: History and use

GelMA-based bioactive hydrogel scaffolds with multiple bone defect repair functions: therapeutic strategies and recent advances

Decellularized extracellular matrix as a promising biomaterial for musculoskeletal tissue regeneration

Decellularized Antler Cancellous Bone Matrix Material Can Serve as Potential Bone Tissue Scaffold

Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials

Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue

Recent Advances in Biomaterials for the Treatment of Bone Defects